All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
CDNA / CareDx, Inc
|
|
|
|
|
|
|
|
STXS / Stereotaxis, Inc.
|
|
|
|
|
|
|
|
MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
EXAC / Exactech, Inc.
|
|
|
|
|
|
|
|
AMPE / Ampio Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NSPR / InspireMD, Inc.
|
|
|
|
|
|
|
|
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
|
|
|
|
|
|
ASPX / Auspex Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
87611RAA6 / Targacept Inc Bond
|
|
|
|
|
|
|
|
ECIA / Encision Inc.
|
|
|
|
|
|
|
|
PCYC / Pharmacyclics
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
CYTR / LadRx Corp
|
|
|
|
|
|
|
|
RIOT / Riot Platforms, Inc.
|
|
|
|
|
|
|
|
JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
VXRT / Vaxart, Inc.
|
|
|
|
|
|
|
|
APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
CYNA / Cynapsus Therapeutics Inc.
|
|
|
|
|
|
|
|
45784PAD3 / Insulet Corp. Bond
|
|
|
|
|
|
|
|
IPCI / Intellipharmaceutics International Inc.
|
|
|
|
|
|
|
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
CLTX / Celsus Therapeutics
|
|
|
|
|
|
|
|
NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
UPI / Uroplasty Inc
|
|
|
|
|
|
|
|
XNPT / XenoPort, Inc.
|
|
|
|
|
|
|
|
US74975N1054 / RTI Surgical, Inc.
|
|
|
|
|
|
|
|
CEMI / Chembio Diagnostics Inc.
|
|
|
|
|
|
|
|
US0909311062 / BioSpecifics Technologies Corp.
|
|
|
|
|
|
|
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
|
|
|
|
|
DXTR / Dextera Surgical Inc.
|
|
|
|
|
|
|
|
ELOS / Syneron Medical Ltd.
|
|
|
|
|
|
|
|
CUTR / Cutera, Inc.
|
|
|
|
|
|
|
|
RVP / Retractable Technologies, Inc.
|
|
|
|
|
|
|
|
670704AC9 / NuVasive, Inc. Bond
|
|
|
|
|
|
|
|
KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
GNVC / GenVec, Inc.
|
|
|
|
|
|
|
|
WINT / Windtree Therapeutics, Inc.
|
|
|
|
|
|
|
|
AASTROM BIOSCIENCES INC
/ COM PAR$ (00253U404) |
|
|
|
|
|
|
|
NWBO / Northwest Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
REGADO BIOSCIENCES INC
/ (75874Q107) |
|
|
|
|
|
|
|
LMNS / Lumenis Ltd
|
|
|
|
|
|
|
|
GBIM / GlobeImmune, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US0906721065 / BioTelemetry, Inc.
|
|
|
|
|
|
|
|
SPNC / Spectranetics Corp. (The)
|
|
|
|
|
|
|
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
|
|
|
|
|
PLX / Protalix BioTherapeutics, Inc.
|
|
|
|
|
|
|
|
CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
BLFS / BioLife Solutions, Inc.
|
|
|
|
|
|
|
|
PODD / Insulet Corporation
|
|
|
|
|
|
|
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
ATRC / AtriCure, Inc.
|
|
|
|
|
|
|
|